1. Home
  2. Programs
  3. On the Frontlines of Metastatic Breast Cancer

Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
  • Overview

    Treatment decisions in metastatic breast cancer hinge on tumor subtype, clinical characteristics, disease burden, and patient preferences. Join Dr. Paolo Tarantino as he explains evidence-based approaches for sequencing therapy across treatment lines while balancing efficacy, toxicity, and individual patient needs. Dr. Tarantino is a medical oncologist and Clinical Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute and Harvard Medical School.

Recommended
Details
Presenters
Related
  • Overview

    Treatment decisions in metastatic breast cancer hinge on tumor subtype, clinical characteristics, disease burden, and patient preferences. Join Dr. Paolo Tarantino as he explains evidence-based approaches for sequencing therapy across treatment lines while balancing efficacy, toxicity, and individual patient needs. Dr. Tarantino is a medical oncologist and Clinical Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute and Harvard Medical School.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free